Agenda

Day 1 - Wednesday, 26 June

8:00 – 8:45
Registration open & coffee

GENERAL SESSION

FUTURE THERAPEUTIC APPROACHES: PRECISION MEDICINE, REGENERATIVE MEDICINE AND NEW MODALITIES

08:45 - 09:00
Opening
9:00 – 9:20
Keynote
1 Turning science into medicine: Power of precision medicine
Dr. Stefan Platz, AstraZeneca
10:20 - 10:45
Fireside chat
10:45 - 11:05
COFFEE BREAK

SESSION 1

CO-CREATION BETWEEN DISCIPLINES AND STAKEHOLDERS

SESSION 2

TRANSFORMING BRAIN AND CNS HEALTH

11:05 – 11:25
Keynote
1 Open science and open innovation
Hitesh Sanganee, AstraZeneca
2 Future development in neurodegenerative diseases and mood disorder treatments
John Isaac, Johnson & Johnson Innovation
12:05 – 12:20
Fire side chat
1 Co-creation at the interface of computing and biology
Hermann Hauser, Amadeus Capital
Jeanette Walker, Cambridge Science Park
2 [12:05 - 12:20] The Human Brain Project
Jan G. Bjaalie, University of Oslo
[12:20 - 12:35] Treating persistent pain
Peter McNaughton, King's College London

GENERAL SESSION

PATIENT-CENTRIC INNOVATION

12:20 - 12:35
Fireside chat
1 Can expensive innovation be accessible and save cost?
Steven Altschuler, Spark Therapeutics
Paul Brackley, Cambridge Independent
13:15 - 13:30
Keynote
1 The future of digital health
Chris Lowe,University of Cambridge
13:30 - 14:30
LUNCH

SESSION 3

DIGITAL DISRUPTORS: AI AND DATA IN HEALTHCARE

SESSION 4

DRUGGING DIFFICULT TARGETS

14:30 - 14:50
Keynote
1 Data in healthcare: from drug discovery to clinical analysis
Kenji Tekada, Microsoft Research
2 Protein misfolding and disease
Tuomas Knowles, University of Cambridge
14:50 - 15:10
Science frontiers keynote
1 Digital health and data in the pharmaceutical industry
Andrew Fried, IBM
2 Systematic ways of targeting difficult drug targets
Malcolm Weir, Sosei-Heptares
15:50 - 16:05
Short Keynote
1 Machine learning and advance tissue imaging analysis
Richard Goodwin, AstraZeneca
2 [16:00 - 16:20] Targeted protein degradation in drug discovery
Alessio Ciulli, University of Dundee
16:05 - 16:20
Keynote
1 DigiTwins project
Lesley Ogilvie, DigiTwins
2
16:20 - 16:40
COFFEE BREAK

SESSION 5

INTEGRATIVE MEDICINE: PUTTING THE PATIENT IN THE CENTRE

SESSION 6

NANOMEDICINE AND NANOTECHNOLOGIES

16:40 - 17:00
Keynote
1 Convergence of food and health
Ian Charles, Quadram Institute
2 Nanotechnologies for the health industry
Lars Montelius, Lund University
[17:00 - 17:15] Delivering medicine with nanotechnology
Sir Mark Welland, University of Cambridge
17:40 - 17:55
Science frontiers Keynote
1 Leveraging the microbiome for precision diagnosis and treatment
Trevor Lawley, Microbiotica
2
17:55 - 18:10
Fireside Chat
1 What is your scientific narrative – integrating KOLs opinions with customer opinions
Gunjan Bhardwaj, Innoplexus
2 Extracellular vesicles in nanomedicines
Joy Wolfram, Mayo Clinic
Simó Schwartz, CIBBIM Nanomedicine
18:10
COCKTAILS

Day 2 - Thursday, 27 June

08:00
Registration open & coffee

GENERAL SESSION

HOW TO REVOLUTIONISE CLINICAL TRIALS

09:00 - 09:20
Keynote
1 Demonstrating value - the necessary tension between controlled vs uncontrolled clinical trials
Rory O'Connor, Pfizer
10:00 - 10:15
Fireside chat
1 Clinical data security, integrity and quality - learnings from the financial industry
Jason Potts, RMIT University
Ann Taylor, Chief Medical Officer, AstraZeneca
Ana Perales, Barclays UK Ventures

GENERAL SESSION

MANAGING CANCER

10:15 - 11:30
Keynote
1 Cancer as a managable disease
Sir Leszek Borysiewicz, Cancer Research UK
11:10 - 11:25
Fireside Chat
1 Advances in cancer treatment and early diagnosis
Jane Grogan, Genentech
Anna Williamson, Roche Pharma Partnering
11:25 - 11:45
COFFEE BREAK

STARTUP PITCHING

11:45 - 13:30

13:30 - 14:30
LUNCH

SESSION 7

THE COST OF HEALTH - NOVEL APPROACHES TO FUNDING INNOVATION

SESSION 8

VIRTUAL REALITY IN CLINICAL PRACTICE AND CARE PROVISION

14:30 - 14:45
Keynote
2 [14:30 - 14:35] Introductury talks
14:45 - 15:30
Moderated Discussion
2 [14:35 - 15:45] Challenges and opportunities of Applied VR in Healthcare
Robert Fine, IVRHA
Fran Ayalasomayajula, HP
Amy Hedrick, Cleanbox Technology
Richard Vincent, FundamentalVR
15:30 - 15:45
Fireside Chat
COFFEE BREAK

SESSION 9

TOWARDS HEALTHY LONGEVITY

SESSION 10

START-UP SHOWCASE

16:05 -16:25
Keynote
1 Ageing as a new therapy area
Aubrey de Grey, SENS Research Foundation
17:05 - 17:25
Science frontiers keynote
1 Ribosomal DNA and novel biomarkers of ageing
Bernardo Lemos, Harvard T.H. Chan School of Public Health
17:25 - 17:45
Fireside chat

STARTUP PITCHING WINNER ANNOUNCEMENT

17:50 - 18:05

18:05
COCKTAIL